- |||||||||| XRD-0394 / XRad Therap
Trial completion, Trial completion date, Trial primary completion date, Combination therapy, Metastases: Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients (clinicaltrials.gov) - Jan 11, 2024
P1, N=12, Completed,
Abstract is embargoed at this time. Active, not recruiting --> Completed | Trial completion date: Dec 2023 --> Jul 2023 | Trial primary completion date: Dec 2023 --> Jul 2023
- |||||||||| XRD-0394 / XRad Therap
Enrollment closed, Enrollment change, Combination therapy, Metastases: Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients (clinicaltrials.gov) - Jul 17, 2023
P1, N=11, Active, not recruiting,
Active, not recruiting --> Completed | Trial completion date: Dec 2023 --> Jul 2023 | Trial primary completion date: Dec 2023 --> Jul 2023 Recruiting --> Active, not recruiting | N=38 --> 11
- |||||||||| XRD-0394 / XRad Therap
Trial completion date, Trial primary completion date, Combination therapy, Metastases: Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients (clinicaltrials.gov) - Feb 8, 2023
P1, N=38, Recruiting,
Recruiting --> Active, not recruiting | N=38 --> 11 Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Dec 2022 --> Dec 2023
|
